{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T07:41:05Z","timestamp":1784360465507,"version":"3.55.0"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2018,2,23]],"date-time":"2018-02-23T00:00:00Z","timestamp":1519344000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009210","name":"Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009210","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Department of Health and Human Services","award":["HHSF223200910006I"],"award-info":[{"award-number":["HHSF223200910006I"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,6,1]]},"DOI":"10.1093\/aje\/kwy023","type":"journal-article","created":{"date-parts":[[2018,2,6]],"date-time":"2018-02-06T04:12:35Z","timestamp":1517890355000},"page":"1269-1276","source":"Crossref","is-referenced-by-count":39,"title":["Assessment of Quadrivalent Human Papillomavirus Vaccine Safety Using the Self-Controlled Tree-Temporal Scan Statistic Signal-Detection Method in the Sentinel System"],"prefix":"10.1093","volume":"187","author":[{"given":"W Katherine","family":"Yih","sequence":"first","affiliation":[{"name":"Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith C","family":"Maro","sequence":"additional","affiliation":[{"name":"Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Office of Biostatistics and Epidemiology, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan A","family":"Baker","sequence":"additional","affiliation":[{"name":"Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Balsbaugh","sequence":"additional","affiliation":[{"name":"Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David V","family":"Cole","sequence":"additional","affiliation":[{"name":"Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inna","family":"Dashevsky","sequence":"additional","affiliation":[{"name":"Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adamma","family":"Mba-Jonas","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Kulldorff","sequence":"additional","affiliation":[{"name":"Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Harvard Medical School and Brigham and Women\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,2,23]]},"reference":[{"issue":"33","key":"key\n\t\t\t\t20180625083752_kwy023C1","doi-asserted-by":"crossref","first-page":"850","DOI":"10.15585\/mmwr.mm6533a4","article-title":"National, regional, state, and selected local area vaccination coverage among adolescents aged 13\u201317 years\u2014United States, 2015","volume":"65","author":"Reagan-Steiner","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"key\n\t\t\t\t20180625083752_kwy023C2","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1542\/peds.2012-2384","article-title":"Reasons for not vaccinating adolescents: National Immunization Survey of Teens, 2008\u20132010","volume":"131","author":"Darden","year":"2013","journal-title":"Pediatrics"},{"issue":"5","key":"key\n\t\t\t\t20180625083752_kwy023C3","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1517\/14740338.2015.1013532","article-title":"Safety of human papillomavirus vaccines: a review","volume":"14","author":"Stillo","year":"2015","journal-title":"Expert Opin Drug Saf"},{"issue":"6","key":"key\n\t\t\t\t20180625083752_kwy023C4","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1080\/21645515.2016.1168952","article-title":"Quadrivalent HPV vaccine safety review and safety monitoring plans for nine-valent HPV vaccine in the United States","volume":"12","author":"Gee","year":"2016","journal-title":"Hum Vaccin Immunother"},{"issue":"12","key":"key\n\t\t\t\t20180625083752_kwy023C5","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1001\/archpediatrics.2012.1451","article-title":"Safety of quadrivalent human papillomavirus vaccine administered routinely to females","volume":"166","author":"Klein","year":"2012","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"2","key":"key\n\t\t\t\t20180625083752_kwy023C6","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1365-2796.2011.02467.x","article-title":"Surveillance of autoimmune conditions following routine use of quadrivalent human papillomavirus vaccine","volume":"271","author":"Chao","year":"2012","journal-title":"J Intern Med"},{"key":"key\n\t\t\t\t20180625083752_kwy023C7","doi-asserted-by":"crossref","first-page":"f5906","DOI":"10.1136\/bmj.f5906","article-title":"Autoimmune, neurological, and venous thromboembolic adverse events after immunisation of adolescent girls with quadrivalent human papillomavirus vaccine in Denmark and Sweden: cohort study","volume":"347","author":"Arnheim-Dahlstr\u00f6m","year":"2013","journal-title":"BMJ"},{"issue":"4","key":"key\n\t\t\t\t20180625083752_kwy023C8","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/joim.12155","article-title":"Autoimmune disorders and quadrivalent human papillomavirus vaccination of young female subjects","volume":"275","author":"Grimaldi-Bensouda","year":"2014","journal-title":"J Intern Med"},{"issue":"12","key":"key\n\t\t\t\t20180625083752_kwy023C9","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1001\/jamaneurol.2014.2633","article-title":"Vaccines and the risk of multiple sclerosis and other central nervous system demyelinating diseases","volume":"71","author":"Langer-Gould","year":"2014","journal-title":"JAMA Neurol"},{"issue":"1","key":"key\n\t\t\t\t20180625083752_kwy023C10","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1001\/jama.2014.16946","article-title":"Quadrivalent HPV vaccination and risk of multiple sclerosis and other demyelinating diseases of the central nervous system","volume":"313","author":"Scheller","year":"2015","journal-title":"JAMA"},{"issue":"1","key":"key\n\t\t\t\t20180625083752_kwy023C11","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.vaccine.2015.10.006","article-title":"Absence of venous thromboembolism risk following quadrivalent human papillomavirus vaccination, Vaccine Safety Datalink, 2008\u20132011","volume":"34","author":"Naleway","year":"2016","journal-title":"Vaccine"},{"issue":"1","key":"key\n\t\t\t\t20180625083752_kwy023C12","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.vaccine.2015.09.087","article-title":"Evaluation of the risk of venous thromboembolism after quadrivalent human papillomavirus vaccination among US females","volume":"34","author":"Yih","year":"2016","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180625083752_kwy023C13","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jaut.2017.01.005","article-title":"Risk of automimmune diseases and human papilloma virus (HPV) vaccines: six years of case-referent surveillance","volume":"79","author":"Grimaldi-Bensouda","year":"2017","journal-title":"J Autoimmun"},{"issue":"33","key":"key\n\t\t\t\t20180625083752_kwy023C14","doi-asserted-by":"crossref","first-page":"4203","DOI":"10.1016\/j.vaccine.2017.06.031","article-title":"HPV vaccination and risk of chronic fatigue syndrome\/myalgic encephalomyelitis: a nationwide register-based study from Norway","volume":"35","author":"Feiring","year":"2017","journal-title":"Vaccine"},{"issue":"36","key":"key\n\t\t\t\t20180625083752_kwy023C15","doi-asserted-by":"crossref","first-page":"4761","DOI":"10.1016\/j.vaccine.2017.06.030","article-title":"Human papillomavirus vaccination and risk of autoimmune diseases: a large cohort study of over 2 million young girls in France","volume":"35","author":"Miranda","year":"2017","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180625083752_kwy023C16","author":"Sukumaran","year":"2015"},{"issue":"7","key":"key\n\t\t\t\t20180625083752_kwy023C17","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1001\/jama.2009.1201","article-title":"Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine","volume":"302","author":"Slade","year":"2009","journal-title":"JAMA"},{"issue":"1","key":"key\n\t\t\t\t20180625083752_kwy023C18","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s40264-016-0456-3","article-title":"Current safety concerns with human papillomavirus vaccine: a cluster analysis of reports in Vigibase\u00ae","volume":"40","author":"Chandler","year":"2017","journal-title":"Drug Saf"},{"issue":"36","key":"key\n\t\t\t\t20180625083752_kwy023C19","doi-asserted-by":"crossref","first-page":"4398","DOI":"10.1016\/j.vaccine.2015.07.035","article-title":"Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS)","volume":"33","author":"Shimabukuro","year":"2015","journal-title":"Vaccine"},{"issue":"4","key":"key\n\t\t\t\t20180625083752_kwy023C20","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00006454-200404000-00002","article-title":"Understanding vaccine safety information from the Vaccine Adverse Event Reporting System","volume":"23","author":"Varricchio","year":"2004","journal-title":"Pediatr Infect Dis J"},{"issue":"9","key":"key\n\t\t\t\t20180625083752_kwy023C21","doi-asserted-by":"crossref","first-page":"599","DOI":"10.3928\/0090-4481-20040901-11","article-title":"The role of the Vaccine Adverse Event Reporting System (VAERS) in monitoring vaccine safety","volume":"33","author":"Iskander","year":"2004","journal-title":"Pediatr Ann"},{"issue":"1","key":"key\n\t\t\t\t20180625083752_kwy023C22","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3390\/pharmaceutics5010179","article-title":"Drug adverse event detection in health plan data using the Gamma Poisson Shrinker and comparison to the tree-based scan statistic","volume":"5","author":"Brown","year":"2013","journal-title":"Pharmaceutics"},{"issue":"5","key":"key\n\t\t\t\t20180625083752_kwy023C23","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/pds.3423","article-title":"Drug safety data mining with a tree-based scan statistic","volume":"22","author":"Kulldorff","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"2","key":"key\n\t\t\t\t20180625083752_kwy023C24","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/1541-0420.00039","article-title":"A tree-based scan statistic for database disease surveillance","volume":"59","author":"Kulldorff","year":"2003","journal-title":"Biometrics"},{"issue":"suppl 1","key":"key\n\t\t\t\t20180625083752_kwy023C25","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/pds.2336","article-title":"Design considerations, architecture, and use of the Mini-Sentinel distributed data system","volume":"21","author":"Curtis","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"suppl 1","key":"key\n\t\t\t\t20180625083752_kwy023C26","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/pds.2323","article-title":"The Food and Drug Administration\u2019s Post-Licensure Rapid Immunization Safety Monitoring program: strengthening the federal vaccine safety enterprise","volume":"21","author":"Nguyen","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"3","key":"key\n\t\t\t\t20180625083752_kwy023C27","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/cpt.320","article-title":"The FDA\u2019s sentinel initiative\u2014a comprehensive approach to medical product surveillance","volume":"99","author":"Ball","year":"2016","journal-title":"Clin Pharmacol Ther"},{"key":"key\n\t\t\t\t20180625083752_kwy023C28","author":"Healthcare Cost and Utilization Project, Agency for Healthcare Research and Quality, US Department of Health and Human Services"},{"key":"key\n\t\t\t\t20180625083752_kwy023C29","author":"Kulldorff","year":"2014"},{"key":"key\n\t\t\t\t20180625083752_kwy023C30","author":"Cole","year":"2016"},{"key":"key\n\t\t\t\t20180625083752_kwy023C31","author":"Merck & Company, Inc","year":"2006"},{"key":"key\n\t\t\t\t20180625083752_kwy023C32","author":"Merck & Company, Inc","year":"2013"},{"issue":"19","key":"key\n\t\t\t\t20180625083752_kwy023C33","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.2169\/internalmedicine.53.3133","article-title":"Peripheral sympathetic nerve dysfunction in adolescent Japanese girls following immunization with the human papillomavirus vaccine","volume":"53","author":"Kinoshita","year":"2014","journal-title":"Intern Med"},{"issue":"22","key":"key\n\t\t\t\t20180625083752_kwy023C34","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1016\/j.vaccine.2015.03.098","article-title":"Orthostatic intolerance and postural tachycardia syndrome as suspected adverse effects of vaccination against human papilloma virus","volume":"33","author":"Brinth","year":"2015","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180625083752_kwy023C35","author":"Pharmacovigilance Risk Assessment Committee, European Medicines Agency","year":"2015"},{"issue":"1","key":"key\n\t\t\t\t20180625083752_kwy023C36","first-page":"30","article-title":"Human papillomavirus vaccines, complex regional pain syndrome, postural orthostatic tachycardia syndrome, and autonomic dysfunction\u2014a review of the regulatory evidence from the European Medicines Agency","volume":"2","author":"Jefferson","year":"2017","journal-title":"Indian J Med Ethics"},{"issue":"12","key":"key\n\t\t\t\t20180625083752_kwy023C37","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s40264-017-0593-3","article-title":"Safety concerns with HPV vaccines continue to linger: are current vaccine pharmacovigilance practices sufficient?","volume":"40","author":"Chandler","year":"2017","journal-title":"Drug Saf"},{"key":"key\n\t\t\t\t20180625083752_kwy023C38","author":"WorkSafeBC Evidence-Based Practice Group, WorkSafeBC, Government of British Columbia","year":"2011"},{"key":"key\n\t\t\t\t20180625083752_kwy023C39","author":"Yih","year":"2016"}],"container-title":["American Journal of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/aje\/article-pdf\/187\/6\/1269\/25082255\/kwy023.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T23:55:53Z","timestamp":1589846153000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/aje\/article\/187\/6\/1269\/4904164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,23]]},"references-count":39,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2018,2,23]]},"published-print":{"date-parts":[[2018,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/aje\/kwy023","relation":{},"ISSN":["0002-9262","1476-6256"],"issn-type":[{"value":"0002-9262","type":"print"},{"value":"1476-6256","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,6]]},"published":{"date-parts":[[2018,2,23]]}}}